- Home
- CNTX vs CURR Comparison
CNTX vs CURR Comparison
Compare CNTX & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- CURR
- Stock Information
- Founded
- CNTX 2015
- CURR 2013
- Country
- CNTX United States
- CURR Singapore
- Employees
- CNTX N/A
- CURR N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- CURR Business Services
- Sector
- CNTX Health Care
- CURR Consumer Discretionary
- Exchange
- CNTX Nasdaq
- CURR Nasdaq
- Market Cap
- CNTX 78.0M
- CURR 113.4M
- IPO Year
- CNTX 2021
- CURR N/A
- Fundamental
- Price
- CNTX $0.81
- CURR $2.06
- Analyst Decision
- CNTX Strong Buy
- CURR Strong Buy
- Analyst Count
- CNTX 5
- CURR 1
- Target Price
- CNTX $5.50
- CURR $3.50
- AVG Volume (30 Days)
- CNTX 193.2K
- CURR 2.8M
- Earning Date
- CNTX 08-06-2025
- CURR 08-11-2025
- Dividend Yield
- CNTX N/A
- CURR N/A
- EPS Growth
- CNTX N/A
- CURR N/A
- EPS
- CNTX N/A
- CURR N/A
- Revenue
- CNTX N/A
- CURR $43,386,858.00
- Revenue This Year
- CNTX N/A
- CURR N/A
- Revenue Next Year
- CNTX N/A
- CURR $21.53
- P/E Ratio
- CNTX N/A
- CURR N/A
- Revenue Growth
- CNTX N/A
- CURR N/A
- 52 Week Low
- CNTX $0.49
- CURR $0.33
- 52 Week High
- CNTX $2.75
- CURR $7.08
- Technical
- Relative Strength Index (RSI)
- CNTX 57.85
- CURR N/A
- Support Level
- CNTX $0.82
- CURR N/A
- Resistance Level
- CNTX $0.88
- CURR N/A
- Average True Range (ATR)
- CNTX 0.07
- CURR 0.00
- MACD
- CNTX 0.00
- CURR 0.00
- Stochastic Oscillator
- CNTX 42.87
- CURR 0.00
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.